Appili Therapeutics (APLIF) Short Interest Ratio & Short Volume $0.01 0.00 (0.00%) As of 06/13/2025 Add Compare Share Share Short Interest Stock AnalysisChartEarningsHeadlinesShort InterestBuy This Stock Appili Therapeutics Short Interest DataAppili Therapeutics (APLIF) has a short interest of 80,300 shares. This marks a -24.60% decrease in short interest from the previous month. The short interest ratio (days to cover) is 1.2, indicating that it would take 1.2 days of the average trading volume of 85,603 shares to cover all short positions.Current Short Interest80,300 sharesPrevious Short Interest106,500 sharesChange Vs. Previous Month-24.60%Dollar Volume Sold Short$1.57 thousandShort Interest Ratio1.2 Days to CoverLast Record DateApril 30, 2025Outstanding Shares121,266,000 sharesPercentage of Shares Shorted0.07%Today's Trading Volume0 sharesAverage Trading Volume85,603 sharesToday's Volume Vs. Average0% Short Selling Appili Therapeutics? Sign up to receive the latest short interest report for Appili Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartAPLIF Short Interest Over TimeAPLIF Days to Cover Over TimeAPLIF Percentage of Float Shorted Over Time Appili Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/202580,300 shares $1.57 thousand -24.6%N/A1.2 $0.02 4/15/2025106,500 shares $2.34 thousand +6.2%0.1%1.5 $0.02 3/31/2025100,300 shares $2.48 thousand -17.2%0.1%0.5 $0.02 3/15/2025121,200 shares $2.79 thousand +584.8%0.1%1.5 $0.02 2/28/202517,700 shares $440.73 +785.0%0.0%0.1 $0.02 2/15/20252,000 shares $46.20 No Change0.0%0 $0.02 1/31/20252,000 shares $46.40 -85.5%N/A0 $0.02 1/15/202513,800 shares $353.28 -55.9%N/A0.3 $0.03 12/31/202431,300 shares $876.40 No ChangeN/A0.8 $0.03 11/30/2024137,600 shares $3.58 thousand +143.1%N/A2.7 $0.03 Get the Latest News and Ratings for APLIF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Appili Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 11/15/202456,600 shares $1.32 thousand +625.6%N/A0.2 $0.02 10/31/20247,800 shares $206.70 +310.5%N/A0 $0.03 10/15/20241,900 shares $45.22 -99.0%N/A0 $0.02 9/30/2024198,900 shares $5.17 thousand No ChangeN/A0.7 $0.03 8/31/20241,000 shares $29.10 -94.4%N/A0 $0.03 8/15/202417,800 shares $428.98 +2,866.7%N/A0.1 $0.02 7/31/2024600 shares $15.88 No ChangeN/A0 $0.03 6/15/202427,300 shares $839.75 -3.5%N/A0.4 $0.03 5/31/202428,300 shares $724.48 -28.4%N/A0.2 $0.03 5/15/202439,500 shares $1.03 thousand +26.2%N/A0.3 $0.03 4/30/202431,300 shares $939.00 -16.3%N/A1 $0.03 4/15/202437,400 shares $942.48 -69.9%N/A0 $0.03 3/31/2024124,200 shares $2.66 thousand +42.9%N/A7.2 $0.02 3/15/202486,900 shares $1.93 thousand +16.5%N/A0.3 $0.02 2/29/202474,600 shares $1.62 thousand +106.1%N/A0.1 $0.02 2/15/202436,200 shares $807.26 -5.0%N/A0.2 $0.02 1/15/202439,300 shares $884.25 -4.8%N/A0.1 $0.02 12/31/202341,300 shares $1.09 thousand -2.1%N/A0.6 $0.03 12/15/202342,200 shares $1.06 thousand -2.3%N/A1.3 $0.03 11/30/202343,200 shares $1.03 thousand -47.4%N/A0.3 $0.02 11/15/202382,100 shares $1.81 thousand +81.6%N/A1.1 $0.02 10/31/202345,200 shares $1.30 thousand -35.8%N/A0.4 $0.03 10/15/202370,400 shares $2.11 thousand +4.1%N/A0.2 $0.03 9/30/202367,600 shares $2.80 thousand +37.4%N/A0 $0.04 9/15/202349,200 shares $1.97 thousand No ChangeN/A0.3 $0.04 8/31/202349,200 shares $1.97 thousand -53.7%N/A0.2 $0.04 8/15/2023106,200 shares $3.82 thousand -33.8%N/A0.2 $0.04 7/31/2023160,400 shares $7.19 thousand +226.0%N/A0.1 $0.04 7/15/202349,200 shares $1.52 thousand -22.2%N/A0.1 $0.03 6/30/202363,200 shares $1.39 thousand +14.5%N/A0.5 $0.02An AI run of epic proportions is only getting started (Ad)I just put together an urgent new presentation that you need to see right away. In short: I believe we are mere days away from a critical announcement from a key tech leader… One that will officially ignite “AI 2.0” – and potentially send a whole new class of stocks soaring. Click to find out what Nvidia’s CEO might reveal… and how Sykes is preparing to ride the wave. 6/15/202355,200 shares $1.27 thousand +10.0%N/A2.7 $0.02 5/31/202350,200 shares $1.42 thousand -3.3%N/A3.3 $0.03 5/15/202351,900 shares $1.39 thousand +1.4%N/A0.8 $0.03 4/30/202351,200 shares $1.51 thousand No ChangeN/A1 $0.03 4/15/202351,200 shares $1.32 thousand No ChangeN/A13.8 $0.03 3/31/202351,200 shares $1.30 thousand No ChangeN/A0.5 $0.03 3/15/202351,200 shares $1.72 thousand -4.5%N/A7.9 $0.03 2/28/202353,600 shares $1.82 thousand +4.7%N/A5.7 $0.03 2/15/202351,200 shares $4.10 thousand -1.9%N/A0.9 $0.08 1/31/202352,200 shares $2.12 thousand No ChangeN/A1.9 $0.04 1/15/202352,200 shares $2.45 thousand -13.9%N/A3.5 $0.05 12/30/202260,600 shares $2.19 thousand -10.2%N/A0.7 $0.04 12/15/202267,500 shares $3.00 thousand +12.1%N/A1.6 $0.04 11/30/202260,200 shares $2.10 thousand -10.4%N/A7.3 $0.03 11/15/202267,200 shares $2.20 thousand -6.9%N/A2.4 $0.03 10/31/202272,200 shares $3.05 thousand -5.3%N/A14.7 $0.04 10/15/202276,200 shares $2.74 thousand -1.3%N/A8.9 $0.04 9/30/202277,200 shares $3.01 thousand -1.3%N/A0.9 $0.04 9/15/202278,200 shares $3.50 thousand -33.2%N/A1.7 $0.04 8/31/2022117,100 shares $5.49 thousand -17.0%N/A8.9 $0.05 8/15/2022141,100 shares $8.70 thousand +7.1%N/A13.7 $0.06 7/31/2022131,700 shares $6.78 thousand +24.6%N/A13.7 $0.05 7/15/2022105,700 shares $5.35 thousand +16.4%N/A1.8 $0.05 6/30/202290,800 shares $5.28 thousand No ChangeN/A2.4 $0.06 6/15/202290,800 shares $4.94 thousand -44.3%N/A4.5 $0.05 5/31/2022162,900 shares $9.77 thousand -0.8%N/A8.8 $0.06 5/15/2022164,200 shares $12.73 thousand -16.8%N/A10.9 $0.08 4/30/2022197,400 shares $16.59 thousand -14.0%N/A23.5 $0.08 4/15/2022229,400 shares $21.24 thousand +1.1%N/A3.6 $0.09 3/31/2022226,900 shares $22.19 thousand -3.5%N/A24.4 $0.10 3/15/2022235,100 shares $20.01 thousand +9.4%N/A2.3 $0.09 2/28/2022214,900 shares $23.79 thousand -8.9%N/A3 $0.11 2/15/2022235,900 shares $22.81 thousand +2.3%N/A3.3 $0.10 1/31/2022230,700 shares $21.78 thousand +61.0%N/A1.6 $0.09 1/15/2022143,300 shares $13.00 thousand +34.2%N/A2 $0.09 12/31/2021106,800 shares $9.58 thousand -53.2%N/A1.6 $0.09 12/15/2021228,000 shares $16.74 thousand +2.6%N/A0.7 $0.07 11/30/2021222,200 shares $26.66 thousand +14.8%N/A0.6 $0.12 11/15/2021193,600 shares $34.91 thousand +15.2%N/A0.3 $0.18 10/29/2021168,000 shares $103.05 thousand +313.8%N/A1.1 $0.61 10/15/202140,600 shares $23.98 thousand -74.2%N/A0.3 $0.59 9/30/2021157,200 shares $135.03 thousand +30.5%N/A1 $0.86 9/15/2021120,500 shares $90.97 thousand +16.2%N/A1.1 $0.75 8/31/2021103,700 shares $64.61 thousand +2.4%N/A1.4 $0.62 8/13/2021101,300 shares $56.73 thousand +3.2%N/A1.4 $0.56 7/30/202198,200 shares $64.08 thousand +2.2%N/A1.7 $0.65 7/15/202196,100 shares $48.05 thousand +15.8%N/A2.7 $0.50 6/30/202183,000 shares $46.34 thousand -6.2%N/A1.1 $0.56 6/15/202188,500 shares $54.12 thousand +19.1%N/A0.5 $0.61 5/28/202174,500 shares $54.17 thousand -8.3%N/A0.5 $0.73An AI run of epic proportions is only getting started (Ad)I just put together an urgent new presentation that you need to see right away. In short: I believe we are mere days away from a critical announcement from a key tech leader… One that will officially ignite “AI 2.0” – and potentially send a whole new class of stocks soaring. Click to find out what Nvidia’s CEO might reveal… and how Sykes is preparing to ride the wave. 5/14/202181,200 shares $71.61 thousand +140.2%N/A0.6 $0.88 4/30/202133,800 shares $34.10 thousand +84.7%N/A0.3 $1.01 4/15/202118,300 shares $14.66 thousand -3.2%N/A0.2 $0.80 3/31/202118,900 shares $16.05 thousand -2.6%N/A0.2 $0.85 3/15/202119,400 shares $16.21 thousand +68.7%N/A0.5 $0.84 2/26/202111,500 shares $10.21 thousand -62.8%N/A0.1 $0.89 2/12/202130,900 shares $33.37 thousand +147.2%N/A0.2 $1.08 1/29/202112,500 shares $9.75 thousand +197.6%N/A0.4 $0.78 1/15/202115,700 shares $13.72 thousand +190.7%N/A0.2 $0.87 12/31/20204,600 shares $4.23 thousand -70.7%N/A0.1 $0.92 12/15/202015,700 shares $16.33 thousand +190.7%N/A0.2 $1.04 11/30/20205,400 shares $5.32 thousand -70.2%N/A0.1 $0.99 11/15/202018,100 shares $16.68 thousand +805.0%N/A0.3 $0.92 10/30/20202,000 shares $2.04 thousand -4.8%N/A0.1 $1.02 10/15/20202,100 shares $2.08 thousand +23.5%N/A0.1 $0.99 APLIF Short Interest - Frequently Asked Questions What is Appili Therapeutics' current short interest? Short interest is the volume of Appili Therapeutics shares that have been sold short but have not yet been closed out or covered. As of April 30th, investors have sold 80,300 shares of APLIF short. Learn More on Appili Therapeutics' current short interest. What is a good short interest ratio for Appili Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. APLIF shares currently have a short interest ratio of 1.0. Learn More on Appili Therapeutics's short interest ratio. Is Appili Therapeutics' short interest increasing or decreasing? Appili Therapeutics saw a drop in short interest in the month of April. As of April 30th, there was short interest totaling 80,300 shares, a drop of 24.6% from the previous total of 106,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Appili Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Appili Therapeutics: 180 Life Sciences Corp. (13.12%), Biofrontera Inc. (2.58%), Aptorum Group Limited (1.30%), Ensysce Biosciences, Inc. (8.15%), Indaptus Therapeutics, Inc. (7.91%), CNS Pharmaceuticals, Inc. (3.36%), Mustang Bio, Inc. (3.26%), Incannex Healthcare Inc. (7.08%), Kazia Therapeutics Limited (0.29%), Adial Pharmaceuticals, Inc. (1.73%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Spotify Technology S.A. ($4.67 billion), Charter Communications, Inc. ($4.58 billion), Capital One Financial Co. ($4.47 billion), The Kroger Co. ($2.56 billion), Reddit, Inc. ($2.23 billion), Rivian Automotive, Inc. ($2.16 billion), Live Nation Entertainment, Inc. ($1.90 billion), SoFi Technologies, Inc. ($1.85 billion), Zscaler, Inc. ($1.75 billion), and Omnicom Group Inc. ($1.75 billion). View all of the most shorted stocks. What does it mean to sell short Appili Therapeutics stock? Short selling APLIF is an investing strategy that aims to generate trading profit from Appili Therapeutics as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Appili Therapeutics? A short squeeze for Appili Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of APLIF, which in turn drives the price of the stock up even further. How often is Appili Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including APLIF, twice per month. The most recent reporting period available is April, 30 2025. More Short Interest Resources from MarketBeat Related Companies ATNF Short Squeeze BFRI Short Squeeze APM Short Squeeze ENSC Short Squeeze INDP Short Squeeze CNSP Short Squeeze MBIO Short Squeeze IXHL Short Squeeze KZIA Short Squeeze ADIL Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:APLIF) was last updated on 6/15/2025 by MarketBeat.com Staff From Our PartnersTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredWhy July 22nd Could Mean Big Changes for Social SecurityIn a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredNew Rule Hits in July — The Smart Money Already MovedA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredBanks aren’t ready for this altcoin—are you?Donald Trump just fast-tracked TWO major crypto bills with an August deadline! Your window of opportunity i...Crypto 101 Media | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Appili Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Appili Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
